| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |